Measuring self-efficacy to use vaginal microbicides: The Microbicide Use Self-Efficacy instrument

Sexual Health

Volumn 10, Issue 4, 2013, Pages 339-347

  Fava, Joseph L ^a   Van Den Berg, Jacob J ^a,b   Rosen, Rochelle K ^a,b   Salomon, Liz ^c   Vargas, Sara ^a   Christensen, Anna L ^a   Pinkston, Megan ^a,b   Morrow, Kathleen M ^a,b  

^a MIRIAM HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c FENWAY INSTITUTE   (United States)

Author keywords

HIV prevention; instrument development; STI prevention; women.

Indexed keywords

MICROBICIDE; UNCLASSIFIED DRUG; VAGINAL MICROBICIDE; ANTIINFECTIVE AGENT;

ADULT; AFRICAN AMERICAN; ANALYTIC METHOD; ARTICLE; CONDOM USE; CONSTRUCT VALIDITY; CROSS-SECTIONAL STUDY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RELATION; INTERNAL VALIDITY; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MICROBICIDE USE SELF EFFICACY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PSYCHOMETRY; RELIABILITY; SELF CONCEPT; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SOCIAL PSYCHOLOGY; QUESTIONNAIRE; REPRODUCIBILITY;

ANTI-INFECTIVE AGENTS; FEMALE; HUMANS; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; SELF EFFICACY; SEXUAL BEHAVIOR; SURVEYS AND QUESTIONNAIRES;

EID: 84881169288     PISSN: 14485028     EISSN: 14498987     Source Type: Journal    
DOI: 10.1071/SH13013     Document Type: Article

References (41)

1. Joint United Nations Programme on HIV/AIDS and World Health Organization (UNAIDS). Global report: UNAIDS report on the global AIDS epidemic 2010. Geneva: UNAIDS; 2010
2. Centers for Disease Control and Prevention (CDC). HIV among women. Atlanta: CDC; 2011
3. Centers for Disease Control and Prevention (CDC). HIV surveillance report. Atlanta : CDC; 2010
4. Elias CJ, Coggins C. Female-controlled methods to prevent sexual transmission of HIV. AIDS 1996; 10: S43-51
5. Feldblum PJ, Weir SS, Cates W. The protective effect of condoms and nonoxynol-9 against HIV infection: A response to Wittkowski and colleagues. Am J Public Health 1999; 89(1): 108-10. doi:10.2105/ AJPH.89.1.108-a
6. Alliance for Microbicide Development (AMD). Alliance for Microbicide Development website. Silver Spring: AMD. Available online at: Http://www.microbicide.org [verified 16 May 2013].
7. Global Campaign for Microbicides (GCM). About microbicides. Seattle: GMC. Available online at: Http://www.global-campaign. org/about-microbicides.htm [verified 16 May 2013].
8. International Partnership for Microbicides (IPM). What Are Microbicides? Silver Spring: IOPM. Available online at: Http://www. ipmglobal.org/why- microbicides/arv-based-microbicides-and-howthey- work/what-are-microbicides. [verified 16 May 2013].
9. Watts C, Vickerman P. The impact of microbicides on HIV and STD transmission: Model projections. AIDS 2001; 15: S43-4. doi:10.1097/ 00002030-200102001-00064
10. Abdool Karim SS, Richardson BA, Ramjee G, Hoffman IF, Chirenje ZM, Taha T, et al. Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women. AIDS 2011; 25(7): 957-66. doi:10.1097/QAD.0b013e32834541d9
11. Chimienti SN. Top stories of 2008. No good news yet on anti-HIV microbicides. AIDS Clin Care 2009; 21(1): 4
12. Van Damme L, Govinden R, Mirembe FM, Guedou F, Solomon S, Becker ML, et al. Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N Engl J Med 2008; 359(5): 463-72. doi:10.1056/NEJMoa0707957
13. Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010; 329(5996): 1168-74. doi:10.1126/science. 1193748
14. Foss AM, Vickerman PT, Alary M, Watts CH. How much could a microbicide's sexually transmitted infection efficacy contribute to reducing HIV risk and the level of condom use needed to lower risk? Model estimates. Sex Transm Infect 2009; 85(4): 276-82. doi:10.1136/sti.2008.032458
15. Marrazzo J, Ramjee G, Nair G, Palanee T, Mkhize B, Nakabiito C, et al. Pre-exposure prophylaxis for HIV in women: Daily oral tenofovir, oral tenofovir-emtricitabine, or vaginal tenofovir gel in the VOICE Study (MTN 003). In VOICE - what are the implications for rectal microbicide research? International Rectal Microbicide Advocates (IRMA) Teleconference; April 8, 2013
16. Morrow KM, Fava JL, Rosen RK, Christensen AL, Vargas S, Barroso C. Willingness to use microbicides varies by race/ethnicity, experience with prevention products, and partner type. Health Psychol 2007; 26(6): 777-86. doi:10.1037/0278-6133.26.6.777
17. Morrow KM, Fava JL, Rosen RK, Vargas S, Barroso C, Christensen AL, et al. Willingness to use microbicides is affected by the importance of product characteristics, use parameters, and protective properties. J Acquir Immune Defic Syndr 2007; 45(1): 93-101. doi:10.1097/QAI.0b013e3180415ded
18. Bandura A. Self-efficacy: The exercise of control. New York: W.H. Freeman; 1997
19. Forsyth AD, Carey MP. Measuring self-efficacy in the context of HIV risk reduction: Research challenges and recommendations. Health Psychol 1998; 17(6): 559-68. doi:10.1037/0278-6133.17.6.559
20. Baele J, Dusseldorp E, Maes S. Condom use self-efficacy: Effect on intended and actual condom use in adolescents. J Adolesc Health 2001; 28(5): 421-31. doi:10.1016/S1054-139X(00)00215-9
21. Basen-Engquist K, Masse LC, Coyle K, Kirby D, Parcel GS, Banspach S, et al. Validity of scales measuring the psychosocial determinants of HIV/STD-related risk behavior in adolescents. Health Educ Res 1999; 14(1): 25-38. doi:10.1093/her/14.1.25
22. Svenson GR, Ostergren PO, Merlo J, Rastam L. Action control and situational risks in the prevention of HIV and STIs: IOndividual, dyadic, and social influences on consistent condom use in a university population. AIDS Educ Prev 2002; 14(6): 515-31. doi:10.1521/ aeap.14.8.515.24111
23. Crosby R, DiClemente RJ, Wingood GM, Sionean C, Cobb BK, Harrington K, et al. Correct condom application among African- American adolescent females: The relationship to perceived selfefficacy and the association to confirmed STDs. J Adolesc Health 2001; 29(3): 194-9. doi:10.1016/S1054-139X(01)00273-7
24. O'Leary A, Maibach E, Ambrose TK, Jemmott J, Celentano DD. Social cognitive predictors of sexual risk behavior change among STD clinic patients. AIDS Behav 2000; 4: 309-16. doi:10.1023/ A:1026474804172
25. Heinrich LB. Contraceptive self-efficacy in college women. J Adolesc Health 1993; 14(4): 269-76. doi:10.1016/1054-139X(93) 90173-M
26. Lauby JL, Semaan S, O'Connell A, Person B, Vogel A. Factors related to self-efficacy for use of condoms and birth control among women at risk for HIV infection. Women Health 2001; 34(3): 71-91. doi:10.1300/J013v34n03-05
27. Salina D, Razzano L, Lesondak L. Influence of health beliefs, attitudes, and concern about HIV/AIDS on condom use in college women. Journal of Prevention&Intervention in the Community 2000; 19: 41-53
28. Gómez CA, Marin BVO. Gender, culture, and power: Barriers to HIVprevention strategies for women. J Sex Res 1996; 33: 355-62. doi:10.1080/00224499609551853
29. Soet JE, DiIorio C, Dudley WN. Women's self-reported condom use: IOntra and interpersonal factors. Women Health 1998; 27(4): 19-32. doi:10.1300/ J013v27n04-02
30. Sterk CE, Klein H, Elifson KW. Perceived condom use self-efficacy among at-risk women. AIDS Behav 2003; 7(2): 175-82. doi:10.1023/ A:1023950425731
31. Morrow KM, Vargas S, Rosen RK, Christensen AL, Salomon L, Shulman L, et al. The utility of non-proportional quota sampling for recruiting at-risk women for microbicide research. AIDS Behav 2007; 11(4): 586-95. doi:10.1007/s10461- 007-9213-z
32. Cattell RB. The scree test for the number of factors. Multivariate Behav Res 1966; 1: 245-76. doi:10.1207/s15327906mbr0102-10
33. Velicer WF. Determining the number of components from the matrix of partial correlations. Psychometrika 1976; 41: 321-7. doi:10.1007/ BF02293557
34. Horn JL. A rationale and test for the number of factors in factor analysis. Psychometrika 1965; 30: 179-85. doi:10.1007/BF02289447
35. O'Connor BP. SPSS and SAS programs for determining the number of components using parallel analysis and Velicer's MAP test. Behav Res Methods Instrum Comput 2000; 32(3): 396-402. doi:10.3758/ BF03200807
36. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951; 16: 297-334. doi:10.1007/BF02310555
37. Bentler PM. Comparative fit indexes in structural equation models. Psychol Bull 1990; 107: 238-46. doi:10.1037/0033-2909.107.2.238
38. Tucker LR, Lewis C. A reliability coefficient for maximum likelihood factor analysis. Psychometrika 1973; 38: 1-10. doi:10.1007/BF02291170
39. Bentler PM. EQS: A structural equations program. Los Angeles: BMDP Statistical Software; 1989
40. Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Struct Equ Modeling 1999; 6(1): 1-55. doi:10.1080/10705519909540118
41. Coalition Advancing Multipurpose Innovations for Reproductive Health (CAMI). Initiative for multipurpose prevention technologies (IMPT). Folsom: CAMI; 2012. Available online at: Http://www.camihealth. org/ [verified April 2013].